| Literature DB >> 25807992 |
Yan Li1, Wei Wang2, Ping Huang2, Qian Zhang3, Xiujuan Yao3, Jingjing Wang4, Zhe Lv2, Yunqing An2, Chris J Corrigan5, Kewu Huang1, Sun Ying2,5.
Abstract
Interleukin-25 (IL-25) and IL-33, which belong to distinct cytokine families, induce and promote T helper type 2 airway inflammation. Both cytokines probably play a role in asthma, but there is a lack of direct evidence to clarify distinctions between their functions and how they might contribute to distinct 'endotypes' of disease. To address this, we made a direct comparison of the effects of IL-25 and IL-33 on airway inflammation and physiology in our established murine asthma surrogate, which involves per-nasal, direct airway challenge. Intranasal challenge with IL-33 or IL-25 induced inflammatory cellular infiltration, collagen deposition, airway smooth muscle hypertrophy, angiogenesis and airway hyper-responsiveness, but neither increased systemic production of IgE or IgG1. Compared with that of IL-25, the IL-33-induced response was characterized by more sustained laying down of extracellular matrix protein, neoangiogenesis, T helper type 2 cytokine expression and elevation of tissue damping. Hence, both IL-25 and IL-33 may contribute significantly and independently to asthma 'endotypes' when considering molecular targets for the treatment of human disease.Entities:
Keywords: asthma; interleukin-25; interleukin-33; remodelling
Mesh:
Substances:
Year: 2015 PMID: 25807992 PMCID: PMC4515131 DOI: 10.1111/imm.12465
Source DB: PubMed Journal: Immunology ISSN: 0019-2805 Impact factor: 7.397